Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth

被引:266
作者
Wang, Hui [2 ]
Lathia, Justin D. [1 ]
Wu, Qiulian [1 ]
Wang, Jialiang [3 ]
Li, Zhizhong [2 ]
Heddleston, John M. [1 ]
Eyler, Christine E. [1 ,2 ]
Elderbroom, Jennifer [2 ]
Gallagher, Joseph [1 ]
Schuschu, Jesse [1 ]
MacSwords, Jennifer [1 ]
Cao, Yiting [3 ]
McLendon, Roger E. [4 ]
Wang, Xiao-Fan [2 ]
Hjelmeland, Anita B. [1 ]
Rich, Jeremy N. [1 ]
机构
[1] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA
[2] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA
[3] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
关键词
cancer stem cells; glioblastoma; interleukin; 6; STAT3; GLIOBLASTOMA-MULTIFORME; STAT3; ACTIVATION; CANCER; PROLIFERATION; APOPTOSIS; IL-6; EXPRESSION; RESISTANCE; HYPOXIA;
D O I
10.1002/stem.188
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Glioblastomas are the most common and most lethal primary brain tumor. Recent studies implicate an important role for a restricted population of neoplastic cells (glioma stem cells (GSCs)) in glioma maintenance and recurrence. We now demonstrate that GSCs preferentially express two interleukin 6 (IL6) receptors: IL6 receptor alpha (IL6R alpha) and glycoprotein 130 ( gp130). Targeting IL6R alpha or IL6 ligand expression in GSCs with the use of short hairpin RNAs (shRNAs) significantly reduces growth and neurosphere formation capacity while increasing apoptosis. Perturbation of IL6 signaling in GSCs attenuates signal transducers and activators of transcription three (STAT3) activation, and small molecule inhibitors of STAT3 potently induce GSC apoptosis. These data indicate that STAT3 is a downstream mediator of prosurvival IL6 signals in GSCs. Targeting of IL6R alpha or IL6 expression in GSCs increases the survival of mice bearing intracranial human glioma xenografts. IL6 is clinically significant because elevated IL6 ligand and receptor expression are associated with poor glioma patient survival. The potential utility of anti-IL6 therapies is demonstrated by decreased growth of subcutaneous human GSC-derived xenografts treated with IL6 antibody. Together, our data indicate that IL6 signaling contributes to glioma malignancy through the promotion of GSC growth and survival, and that targeting IL6 may offer benefit for glioma patients. STEM CELLS 2009;27:2393-2404
引用
收藏
页码:2393 / 2404
页数:12
相关论文
共 35 条
[1]   Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis [J].
Ancrile, Brooke ;
Lim, Kian-Huat ;
Counter, Christopher M. .
GENES & DEVELOPMENT, 2007, 21 (14) :1714-1719
[2]   Targeting cancer stem cells through L1CAM suppresses glioma growth [J].
Bao, Shideng ;
Wu, Qiulian ;
Li, Zhizhong ;
Sathornsumetee, Sith ;
Wang, Hui ;
McLendon, Roger E. ;
Hjehneland, Anita B. ;
Rich, Jeremy N. .
CANCER RESEARCH, 2008, 68 (15) :6043-6048
[3]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[4]   Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor [J].
Bao, Shideng ;
Wu, Qiulian ;
Sathornsumetee, Sith ;
Hao, Yueling ;
Li, Zhizhong ;
Hjelmeland, Anita B. ;
Shi, Oing ;
McLendon, Roger E. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
CANCER RESEARCH, 2006, 66 (16) :7843-7848
[5]  
*CENTR BRAIN TUM R, 2005, STAT REP PRIM BRAIN
[6]   Fas engagement increases expression of interleukin-6 in human glioma cells [J].
Choi, C ;
Gillespie, GY ;
Van Wagoner, NJ ;
Benveniste, EN .
JOURNAL OF NEURO-ONCOLOGY, 2002, 56 (01) :13-19
[7]  
Conze D, 2001, CANCER RES, V61, P8851
[8]   Chemotherapy resistance of glioblastoma stem cells [J].
Eramo, A. ;
Ricci-Vitiani, L. ;
Zeuner, A. ;
Pallini, R. ;
Lotti, F. ;
Sette, G. ;
Pilozzi, E. ;
Larocca, L. M. ;
Peschle, C. ;
De Maria, R. .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (07) :1238-1241
[9]   Hypoxia - A key regulatory factor in tumour growth [J].
Harris, AL .
NATURE REVIEWS CANCER, 2002, 2 (01) :38-47
[10]   Cancerous stem cells can arise from pediatric brain tumors [J].
Hemmati, HD ;
Nakano, I ;
Lazareff, JA ;
Masterman-Smith, M ;
Geschwind, DH ;
Bronner-Fraser, M ;
Kornblum, HI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :15178-15183